MyAverix Finance
US · Healthcare
Seelos Therapeutics, Inc. (SEELQ)
Biotechnology
Seelos Therapeutics, Inc. (SEELQ) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SEELQ
Seelos Therapeutics, Inc. (SEELQ) — FAQ
What is SEELQ's P/E ratio?
The price-to-earnings (P/E) ratio for Seelos Therapeutics, Inc. (SEELQ) is 25.00 (data as of 2026-05-23).
Does Seelos Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Seelos Therapeutics, Inc. (SEELQ). Check the MyAverix Finance app for the latest dividend data.
What sector is Seelos Therapeutics, Inc. in?
Seelos Therapeutics, Inc. (SEELQ) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SEELQ listed on?
SEELQ is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.